A stable parenteral dosage form of cetrorelix acetate

The present invention relates to a stable parenteral dosage form with a ready-to-inject sterile stable aqueous solution of Cetrorelix acetate. The invention also relates to an injection device prefilled with the ready-to-inject sterile stable aqueous solution of Cetrorelix acetate. The present inven...

Full description

Saved in:
Bibliographic Details
Main Authors YADAV Arunkumar, THENNATI Rajamannar, AGRAWAL Sudeep, BHOWMICK Subhas Balaram, JOSHI Jaydip, THUMMAR Rakesh
Format Patent
LanguageEnglish
Hebrew
Published 01.08.2022
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
TESTING
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a stable parenteral dosage form with a ready-to-inject sterile stable aqueous solution of Cetrorelix acetate. The invention also relates to an injection device prefilled with the ready-to-inject sterile stable aqueous solution of Cetrorelix acetate. The present invention relates to a use of a parenteral dosage form comprising a ready-to-inject sterile, stable aqueous solution of Cetrorelix acetate for inhibiting premature luteinizing hormone surges in women undergoing controlled ovarian stimulation.
Bibliography:Application Number: IL20220293908